Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case–control study
- 292 Downloads
Accumulating evidence supports a role for obesity in the etiology of multiple myeloma (MM). The distinct possibility exists that obesity may be linked to MM through altered adipokine secretion and circulating levels, one of which, adiponectin, has a protective role in several malignancies, including leukemia. In this case–control study, we investigated the role of serum adiponectin, resistin, and leptin levels in the etiopathogenesis of MM and we explored their association with several established prognostic factors. Seventy three patients with incident, histologically confirmed MM and 73 controls matched on gender and age were studied between 2001 and 2007, and blood samples were collected. Serum adiponectin, leptin, resistin, as well as MM prognostic parameters were determined. Statistical analysis of the data was performed using univariate and multivariate analyses. Lower serum adiponectin and resistin levels were associated with higher risk of MM by bivariate analysis and after adjusting for age, gender, BMI, and serum levels of leptin (p < 0.0001). Adiponectin may have a protective role in MM, whereas leptin was not associated with risk for MM at a comparable level of significance and resistin levels may be decreased via a compensatory mechanism. Further studies are needed to confirm these associations and to explore the mechanisms underlying adiponectin’s role in MM and plasma cell dyscrasias.
KeywordsAdiponectin Leptin Resistin Adipokine Multiple myeloma
This study was supported by a discretionary grant from BIDMC.
- 1.Foerster J, Paraskevas F (1998) Multiple myeloma. In: Lee GR, Foerster J, Luken J, Paraskevas F, Greer JP, Rodgers GM, Wintrobe MM (eds) Wintrobe’s clinical hematology, vol 2. Lippincott Williams & Wilkins, Baltimore, pp 2631–2655Google Scholar
- 4.Lewis DR, Pottern LM, Brown LM, Silverman DT, Hayes RB, Schoenberg JB, Greenberg RS, Swanson GM, Schwartz AG, Liff JM (1994) Multiple myeloma among blacks and whites in the United States: the role of chronic antigenic stimulation. Cancer Causes Control 5:529–539. doi: 10.1007/BF01831381 PubMedCrossRefGoogle Scholar
- 12.Chan JL, Moschos SJ, Bullen J, Heist K, Li X, Kim YB, Kahn BB, Mantzoros CS (2005) Recombinant methionyl human leptin administration activates signal transducer and activator of transcription 3 signaling in peripheral blood mononuclear cells in vivo and regulates soluble tumor necrosis factor-alpha receptor levels in humans with relative leptin deficiency. J Clin Endocrinol Metab 90:1625–1631. doi: 10.1210/jc.2004-1823 PubMedCrossRefGoogle Scholar
- 24.Lee JH, Chan JL, Yiannakouris N, Kontogianni M, Estrada E, Seip R, Orlova C, Mantzoros CS (2003) Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab 88:4848–4856. doi: 10.1210/jc.2003-030519 PubMedCrossRefGoogle Scholar
- 28.Durie BGM, Salmon SE (1975) A clinical staging system for multiple myeloma: correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival. Cancer 36:842–854. doi :10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-UPubMedCrossRefGoogle Scholar
- 29.SAS/STAT User’s Guide (1989) NC, Cary. Ref Type: Computer ProgramGoogle Scholar
- 34.Chan JL, Matarese G, Shetty GK, Raciti P, Kelesidis I, Aufiero D, De Rosa V, Perna F, Fontana S, Mantzoros CS (2006) Differential regulation of metabolic, neuroendocrine, and immune function by leptin in humans. Proc Natl Acad Sci USA 103:8481–8486. doi: 10.1073/pnas.0505429103 PubMedCrossRefGoogle Scholar
- 37.Kawanami D, Maemura K, Takeda N, Harada T, Nojiri T, Imai Y, Manabe I, Utsunomiya K, Nagai R (2004) Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochem Biophys Res Commun 314:415–419. doi: 10.1016/j.bbrc.2003.12.104 PubMedCrossRefGoogle Scholar